Madrigal Pharmaceuticals (MDGL) News Today $436.95 +0.67 (+0.15%) Closing price 04:00 PM EasternExtended Trading$436.37 -0.58 (-0.13%) As of 05:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MDGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)October 7 at 4:05 PM | globenewswire.comKnights of Columbus Asset Advisors LLC Increases Stock Position in Madrigal Pharmaceuticals, Inc. $MDGLOctober 7 at 4:52 AM | marketbeat.comStrid Group LLC Buys Shares of 2,500 Madrigal Pharmaceuticals, Inc. $MDGLOctober 5 at 5:21 AM | marketbeat.comJ. Safra Sarasin Holding AG Increases Holdings in Madrigal Pharmaceuticals, Inc. $MDGLOctober 4, 2025 | marketbeat.comQ3 Earnings Forecast for MDGL Issued By B. RileyOctober 4, 2025 | americanbankingnews.comWhat is B. Riley's Forecast for MDGL Q3 Earnings?October 2, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Holdings Decreased by AMI Asset Management CorpOctober 2, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Sets New 1-Year High Following Analyst UpgradeOctober 2, 2025 | americanbankingnews.comMadrigal Pharmaceuticals price target raised to $560 from $460 at B. RileyOctober 1, 2025 | msn.comAnalyzing Madrigal Pharmaceuticals (NASDAQ:MDGL) and Zoetis (NYSE:ZTS)October 1, 2025 | americanbankingnews.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Stock Price Expected to Rise, B. Riley Analyst SaysOctober 1, 2025 | americanbankingnews.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 52-Week High After Analyst UpgradeSeptember 30, 2025 | marketbeat.comMadrigal Pharmaceuticals: Rezdiffra's US And EU Rollout Remains PromisingSeptember 30, 2025 | seekingalpha.comB. Riley Securities Maintains Madrigal Pharmaceuticals (MDGL) Buy RecommendationSeptember 30, 2025 | msn.comA Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 7 AnalystsSeptember 29, 2025 | benzinga.comB. Riley Issues Positive Forecast for Madrigal Pharmaceuticals (NASDAQ:MDGL) Stock PriceSeptember 29, 2025 | marketbeat.comMadrigal Pharmaceuticals (MDGL) Gets a Buy from UBSSeptember 26, 2025 | theglobeandmail.comStrs Ohio Makes New $629,000 Investment in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 21, 2025 | marketbeat.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)September 18, 2025 | globenewswire.comRoche deal to buy 89bio boosts MASH spaceSeptember 18, 2025 | msn.comMadrigal Pharmaceuticals management to meet with B. RileySeptember 17, 2025 | msn.comIntech Investment Management LLC Purchases 1,696 Shares of Madrigal Pharmaceuticals, Inc. $MDGLSeptember 15, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Given Average Rating of "Moderate Buy" by AnalystsSeptember 15, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Given New $526.00 Price Target at Canaccord Genuity GroupSeptember 14, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. $MDGL Shares Purchased by Rhumbline AdvisersSeptember 13, 2025 | marketbeat.comMarketBeat Week in Review – 09/08 - 09/12 (MDGL)Markets had another strong week as inflaton data set the stage for the Federal Reserve’s meeting next week; a rate cut is expected but may already be priced in...September 13, 2025 | marketbeat.comEP Wealth Advisors LLC Takes Position in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 13, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 6 AnalystsSeptember 12, 2025 | benzinga.comWilliam John Sibold Sells 7,279 Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL) StockSeptember 11, 2025 | marketbeat.comWoodline Partners LP Buys 8,316 Shares of Madrigal Pharmaceuticals, Inc. $MDGLSeptember 11, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Hits New 12-Month High - What's Next?September 10, 2025 | marketbeat.comCoreWeave and Madrigal's Insider Trades Flash Bullish Signals (MDGL)Insider trades at NVIDIA-backed CoreWeave and Madrigal Pharmaceuticals are bullish indicators, but for very different reasons.September 10, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) CEO William John Sibold Sells 7,279 SharesSeptember 10, 2025 | insidertrades.comA Fresh Look at Madrigal Pharmaceuticals (MDGL) Valuation Following Recent Share Price MomentumSeptember 9, 2025 | finance.yahoo.comWhat is HC Wainwright's Forecast for MDGL Q3 Earnings?September 9, 2025 | marketbeat.comMadrigal Pharmaceuticals, Inc. (MDGL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comCinctive Capital Management LP Reduces Position in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 8, 2025 | marketbeat.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Receives Buy Rating from HC WainwrightSeptember 6, 2025 | marketbeat.comCutter Capital Management LP Purchases New Shares in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 6, 2025 | marketbeat.comAllostery Investments LP Buys Shares of 600 Madrigal Pharmaceuticals, Inc. $MDGLSeptember 5, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Has $63.47 Million Holdings in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 5, 2025 | marketbeat.comMadrigal Pharmaceuticals assumed with a Buy at H.C. WainwrightSeptember 4, 2025 | msn.comTD Cowen Sees Greater Upside in Madrigal (MDGL) Following Recent Rezdiffra ApprovalSeptember 4, 2025 | msn.comMadrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)September 4, 2025 | globenewswire.comMadrigal Pharmaceuticals (NASDAQ:MDGL) Sets New 52-Week High - What's Next?September 4, 2025 | marketbeat.comADAR1 Capital Management LLC Invests $494,000 in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comMPM Bioimpact LLC Makes New Investment in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comQuarry LP Invests $232,000 in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 4, 2025 | marketbeat.comMadrigal Pharmaceuticals to Participate in Morgan Stanley 23rd Annual Global Healthcare ConferenceSeptember 3, 2025 | globenewswire.comPaulson & CO. Inc. Grows Stake in Madrigal Pharmaceuticals, Inc. $MDGLSeptember 3, 2025 | marketbeat.com Get Madrigal Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MDGL Media Mentions By Week MDGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDGL News Sentiment▼0.950.60▲Average Medical News Sentiment MDGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDGL Articles This Week▼1410▲MDGL Articles Average Week Get the Latest News and Ratings for MDGL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Biogen News Today United Therapeutics News Today Incyte News Today Neurocrine Biosciences News Today Ionis Pharmaceuticals News Today Exelixis News Today Exact Sciences News Today BioMarin Pharmaceutical News Today Repligen News Today Halozyme Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDGL) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersTesla’s $30 trillion pivotCircle Nov 6 – huge Tesla news? Tesla could be about to change forever. On November 6, insiders are warning...Altimetry | SponsoredBitcoin at $125,000 is fantastic news… for this coinAs Bitcoin surges past $125,000, one under-the-radar altcoin — faster, cheaper, and already backed by major in...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredAn Early Move On The Next Shift In CoinLitecoin is already processing 500,000+ daily transactions, integrated with PayPal and Revolut, and now one fi...Market Tactic | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
